Compare · OHI vs VTR
OHI vs VTR
Side-by-side comparison of Omega Healthcare Investors Inc. (OHI) and Ventas Inc. (VTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OHI and VTR operate in Real Estate Investment Trusts (Real Estate), so they compete in similar markets.
- VTR is the larger of the two at $39.67B, about 3.0x OHI ($13.26B).
- OHI has been more active in the news (10 items in the past 4 weeks vs 5 for VTR).
- Both have 25 recent analyst ratings on file.
- Company
- Omega Healthcare Investors Inc.
- Ventas Inc.
- Price
- -
- -
- Market cap
- $13.26B
- $39.67B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Real Estate Investment Trusts
- Real Estate Investment Trusts
- Exchange
- NYSE
- NYSE
- IPO
- 1992
- News (4w)
- 10
- 5
- Recent ratings
- 25
- 25
Omega Healthcare Investors Inc.
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Ventas Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries  healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Latest OHI
- Raymond James resumed coverage on Omega Health with a new price target
- SEC Form 4 filed by Director Plavin Stephen D
- Director Egbuonu-Davis Lisa was granted 3,778 shares, increasing direct ownership by 20% to 22,432 units (SEC Form 4)
- SEC Form 4 filed by Director Hill Barbara B
- Director Jacobs Kevin J was granted 6,125 shares, increasing direct ownership by 15% to 46,935 units (SEC Form 4)
- Director Whitman Burke W was granted 3,778 shares, increasing direct ownership by 9% to 47,931 units (SEC Form 4)
- SEC Form 4 filed by Director Anand Kapila K
- SEC Form 4 filed by Director Callen Craig R
- Omega Healthcare Investors Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events
- SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Pickett C Taylor
Latest VTR
- Raymond James resumed coverage on Ventas with a new price target
- Ventas Inc. filed SEC Form 8-K: Leadership Update, Other Events
- Director Embler Michael J bought $197,025 worth of shares (2,500 units at $78.81), increasing direct ownership by 15% to 19,202 units (SEC Form 4)
- Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement
- Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference
- Ventas Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events
- Director Roy Sumit was granted 2,047 shares, increasing direct ownership by 9% to 24,404 units (SEC Form 4)
- Director Smith Maurice S was granted 2,047 shares, increasing direct ownership by 7% to 30,723 units (SEC Form 4)
- Director Rakowich Walter C was granted 2,047 shares and sold $103,915 worth of shares (1,152 units at $90.20) as part of a pre-agreed trading plan, increasing direct ownership by 3% to 28,349 units (SEC Form 4)
- Director Rodriguez Joe Vasquez Jr. was granted 2,047 shares, increasing direct ownership by 26% to 9,895 units (SEC Form 4)